Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The role of primitive neural stem cells in the functional recovery after neonatal brain injury
EF 2020-21
Résumé
Perinatal hypoxic/ischemic (H/I) insult is a prevalent cause of brain injury in infants. Children who suffer from this form of brain injury exhibit long-term neurological complications ranging from mild behavioural deficits to severe seizures, mental retardation, and/or cerebral palsy. Their care and management represent a significant long-term personal, familial, economic, and societal challenge for Canadians. With the exception of rehabilitation, there are currently no established treatments available to improve behavioral deficits in these patients and despite its prevalence and significant impact on the health care system, pediatric ischemia is largely unstudied. A promising therapeutic strategy is neural regeneration through the recruitment of resident neural stem cells that are responsive to drug treatment. Specifically, our lab has previously shown that the activation of resident neural stem and progenitor cells (together termed neural precursor cells, NPCs) using the FDA approved drug metformin, is sufficient to promote functional recovery in a model of neonatal H/I. In my proposed studies, I will focus on understanding the cellular basis for this observed recovery by determining whether neural stem cells are directly contributing to tissue repair. I hypothesize that resident NPCs and their progeny are activated in response to HI and metformin treatment, expand in number, migrate to the site of the injury and differentiate into neural phenotypes to replace lost cells. Elucidating this cellular mechanism will uncover novel targets for future therapeutics. Ultimately, this will promote the health of affected Canadians and reduce the socioeconomic burden on families and the healthcare system.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449347
Name
Noman Humna
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of primitive neural stem cells in the functional recovery after neonatal brain injury
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Injury; Cellular Mechanism; Childhood Brain Injury; Drug Treatment; Neonatal Model; Neural Regeneration; Neural Repair; Neural Stem Cells; Regenerative Medicine; Stroke
Abstract
Perinatal hypoxic/ischemic (H/I) insult is a prevalent cause of brain injury in infants. Children who suffer from this form of brain injury exhibit long-term neurological complications ranging from mild behavioural deficits to severe seizures, mental retardation, and/or cerebral palsy. Their care and management represent a significant long-term personal, familial, economic, and societal challenge for Canadians. With the exception of rehabilitation, there are currently no established treatments available to improve behavioral deficits in these patients and despite its prevalence and significant impact on the health care system, pediatric ischemia is largely unstudied. A promising therapeutic strategy is neural regeneration through the recruitment of resident neural stem cells that are responsive to drug treatment. Specifically, our lab has previously shown that the activation of resident neural stem and progenitor cells (together termed neural precursor cells, NPCs) using the FDA approved drug metformin, is sufficient to promote functional recovery in a model of neonatal H/I. In my proposed studies, I will focus on understanding the cellular basis for this observed recovery by determining whether neural stem cells are directly contributing to tissue repair. I hypothesize that resident NPCs and their progeny are activated in response to HI and metformin treatment, expand in number, migrate to the site of the injury and differentiate into neural phenotypes to replace lost cells. Elucidating this cellular mechanism will uncover novel targets for future therapeutics. Ultimately, this will promote the health of affected Canadians and reduce the socioeconomic burden on families and the healthcare system.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Noman, Humna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~